Individuals find the right products. Businesses reach the right audience. One platform, free for both.
Since 2022, Symbiotics Group has backed 6 African startups across 2 disclosed funding rounds totaling $110M, most heavily in Ghana and Fintech.
Symbiotics Group is a market access platform for impact investing focused on private markets in emerging and frontier economies. Its official site describes the group as offering investment, asset management, and capacity building services. Based on the investment data provided, Symbiotics has backed fintech companies in Africa across early and growth stages, including Series A and Series C rounds. The recorded activity is concentrated in Ghana and South Africa, with investments in Zeepay and Onafriq. This points to a clear focus on fintech and cross-border payments in African markets.
Data updated · Sep 10, 2026
Sign in to see all 6 portfolio products
Free account — full portfolios, timelines, and the weekly funding digest
Sign in to see all 6 rounds
Free account — full portfolios, timelines, and the weekly funding digest
Symbiotics Group has backed 6 African startups across 2 disclosed funding rounds tracked on Liners, totaling $110M since 2022.
Mostly Series A: 1 of its 2 tracked rounds are at that stage, followed by Series C (1).
Companies Symbiotics Group has backed operate in Ghana (6), Nigeria (3), South Africa (3), and 37 more markets. Each figure counts the rounds behind companies serving that market, so a company operating in several markets counts in each of them.
Its tracked rounds lean toward Fintech (4), Agri Tech (1), Energy & Utilities (1).
Symbiotics Group most often shares rounds with FMO Entrepreneurial Development Bank (2 shared deals), Stanbic IBTC Bank (1 shared deal), responsAbility Investments (1 shared deal).
The available records show Symbiotics Group invested in fintech companies in Africa, including Zeepay in Ghana and Onafriq in South Africa. Both companies operate in payments and financial connectivity, which fits the group’s broader focus on impact investing in emerging and frontier markets.
The official site describes Symbiotics Group as a market access platform for impact investing, with investment, asset management, and capacity building services. The Africa deals provided are consistent with that positioning.